A Co-regency is the situation where a monarchical position (such as King, Queen, Emperor or Empress), normally held by only a single person, is held by two.
Historical examples of this include the co-regency of Frederick I of Austria and Louis the Bavarian over the Holy Roman Empire, and the co-regency of William and Mary over England, Scotland, and Ireland. It was also found in the ancient Roman Empire.
A similar situation still exists today in Andorra, which has two Princes (the Bishop of Urgel and the President of France), but since they only hold the rank of Prince, not King, it is referred to as a co-principality rather than a co-regency. The term prince (the female form is princess), from the Latin root princeps, when used for a member of the highest aristocracy, has several fundamentally different meanings - one generic, and several types of titles. ...
In Ancient Egypt, mainly in the Middle Kingdom, the Pharaoh occasionally appointed his successor (often one of his sons) as co-regent, or joint king, to ensure a smooth succession. The Pharaoh also did this when he was elderly or unable to rule his country on his own (such as the case of Thutmose III and Amenhotep II or Amenemhat II and Senusret II). The existence of the practice makes establishing firm dates in Egyptian chronology more of a challenge, as the lengths of co-regencies are often uncertain and complicate the use of accepted regnal lengths to establish dates. Khafres Pyramid (4th dynasty) and Great Sphinx of Giza (c. ... Pharaoh is a title used to refer to any ruler, usually male, of the Egyptian kingdom in the pre-Christian, pre-Islamic period. ... Menkheperre Lasting is the Manifestation of Re Nomen Thutmose Neferkheperu Son of Ra, Thutmose, beautiful of forms Horus name Kanakht Khaemwaset Horus Mighty Bull, Arising in Thebes Nebty name Wahnesytmireempet He of the Two Ladies, Enduring in kingship like Re in heaven Golden Horus Sekhempahtydsejerkhaw Horus of Gold Powerful of... nomen or birth name Aakheperure Amenhotep II (d. ... This article needs to be cleaned up to conform to a higher standard of quality. ...
In the book The Mysterious Numbers of the Hebrew Kings, Edwin R. Thiele proposed co-regency as a possible explanation for discrepancies in the dates given in the Hebrew Bible for the reigns of the kings of Israel and Judah. At least one co-regency is explicitly documented in the Bible: the coronation of King Solomon occurred before the death of his father David. Edwin R. Thiele (1895-1986) was a missionary, writer, archaeologist, and professor of the Old Testament. ... 11th century manuscript of the Hebrew Bible with Targum This article discusses usage of the term Hebrew Bible. For the article on the Hebrew Bible itself, see Tanakh. ... Kingdom of Judah (Hebrew מַלְכוּת יְהוּדָה, Standard Hebrew Malḫut YÉ™huda, Tiberian Hebrew Malḵûṯ YÉ™hûá¸Äh) in the times of the Hebrew Bible, was the nation formed from the territories of the tribes of Judah, Simeon, and Benjamin after the Kingdom of Israel was divided, and was named after Judah... It has been suggested that Sulayman be merged into this article or section. ... Bold textItalic text David and Goliath by Caravaggio, c. ...
Coreg lowers blood pressure and increases the output of the heart.
Coreg side effects may include back pain, bronchitis, chest pain, cough, diarrhea, dizziness, fainting, fatigue, fever, headache, increased blood sugar levels, joint pain, low blood pressure, muscle aches, nausea, pain, respiratory infection, sinus problems, slow heartbeat, sore throat, swelling, urinary infection, vision changes, vomiting, weakness, and weight gain.
Less common Coreg side effects may include allergy, blood in urine, dark stools, feeling of illness, gum disease, high blood pressure, impotence, increased sweating, infection, kidney problems, lack of sensitivity to touch, palpitation, reddish or purplish spots, shortness of breath, sleepiness, tingling or numbness, trouble sleeping, vertigo, and weight loss.
COREG is indicated for the treatment of mild to severe heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitor, and digitalis, to increase survival and, also, to reduce the risk of hospitalization (see CLINICAL TRIALS).
COREG is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of 40% (with or without symptomatic heart failure) (see CLINICAL TRIALS).
COREG should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.
Feeds |
Contact